- Home
- QNCX vs ATLX Comparison
QNCX vs ATLX Comparison
Compare QNCX & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- ATLX
- Stock Information
- Founded
- QNCX 2012
- ATLX 2011
- Country
- QNCX United States
- ATLX Brazil
- Employees
- QNCX N/A
- ATLX N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- QNCX Health Care
- ATLX Industrials
- Exchange
- QNCX Nasdaq
- ATLX Nasdaq
- Market Cap
- QNCX 90.8M
- ATLX 95.1M
- IPO Year
- QNCX 2019
- ATLX N/A
- Fundamental
- Price
- QNCX $1.60
- ATLX $4.58
- Analyst Decision
- QNCX Strong Buy
- ATLX Strong Buy
- Analyst Count
- QNCX 6
- ATLX 1
- Target Price
- QNCX $8.00
- ATLX $19.00
- AVG Volume (30 Days)
- QNCX 124.9K
- ATLX 427.7K
- Earning Date
- QNCX 11-12-2025
- ATLX 11-07-2025
- Dividend Yield
- QNCX N/A
- ATLX N/A
- EPS Growth
- QNCX N/A
- ATLX N/A
- EPS
- QNCX N/A
- ATLX N/A
- Revenue
- QNCX N/A
- ATLX $350,003.00
- Revenue This Year
- QNCX N/A
- ATLX $22,084.55
- Revenue Next Year
- QNCX N/A
- ATLX N/A
- P/E Ratio
- QNCX N/A
- ATLX N/A
- Revenue Growth
- QNCX N/A
- ATLX N/A
- 52 Week Low
- QNCX $0.69
- ATLX $3.54
- 52 Week High
- QNCX $2.45
- ATLX $11.89
- Technical
- Relative Strength Index (RSI)
- QNCX 47.89
- ATLX 42.01
- Support Level
- QNCX $1.56
- ATLX $4.57
- Resistance Level
- QNCX $1.65
- ATLX $5.17
- Average True Range (ATR)
- QNCX 0.08
- ATLX 0.34
- MACD
- QNCX 0.00
- ATLX -0.10
- Stochastic Oscillator
- QNCX 64.65
- ATLX 0.80
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.